HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 8, Pages 1015
Publisher
MDPI AG
Online
2022-08-18
DOI
10.3390/ph15081015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Periplocin and cardiac glycosides suppress the unfolded protein response
- (2021) Muneshige Tokugawa et al. Scientific Reports
- The potential use of simvastatin for cancer treatment: A review
- (2021) Jaqueline Aparecida Duarte et al. BIOMEDICINE & PHARMACOTHERAPY
- Adaptive homeostasis and the p53 isoform network
- (2021) Sunali Mehta et al. EMBO REPORTS
- Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
- (2020) Chiharu Miyajima et al. Cells
- The Innovative Potential of Statins in Cancer: New Targets for New Therapies
- (2020) Elisabetta Di Bello et al. Frontiers in Chemistry
- Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin
- (2020) Yuhao Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21
- (2019) Keishi Fukuura et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
- (2018) Mai Nagasaka et al. MOLECULES
- The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress
- (2017) Yasumichi Inoue et al. FEBS LETTERS
- The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation
- (2017) Matan Shanzer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Mechanisms of Hippo pathway regulation
- (2016) Zhipeng Meng et al. GENES & DEVELOPMENT
- Prognostic significance of TAZ expression in various cancers: a meta-analysis
- (2016) Zhengyu Li et al. OncoTargets and Therapy
- TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
- (2016) Yuki Kawarada et al. Scientific Reports
- Positive Regulation of Interleukin-2 Expression by a Pseudokinase, Tribbles 1, in Activated T Cells
- (2015) Chiharu Miyajima et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
- (2015) Yusuke Oku et al. FEBS Open Bio
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- p53 Acetylation: Regulation and Consequences
- (2014) Sara Reed et al. Cancers
- Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells
- (2013) Lijuan Wang et al. PLoS One
- Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53
- (2010) A K Arya et al. BRITISH JOURNAL OF CANCER
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- TEAD mediates YAP-dependent gene induction and growth control
- (2008) B. Zhao et al. GENES & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search